After participating in this educational activity, attendees should be able to:
1. Recognize the mechanism of action of biologic therapies available for childhood atopic dermatitis.
2. Identify the side effects of biologic therapies available for childhood atopic dermatitis.
3. Restate the efficacy of the biologic therapies for childhood atopic dermatitis.
Richard J. Antaya, MD
Professor of Dermatology, Pediatrics & Nursing
The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Faculty or planner conflicts of interest are resolved before the educational activity.
The speaker attests that he is currently receiving grant/research support from Leo Pharma for a clinical trial and had received royalty from an advisory board.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 BCIPE Instructional Hours